TRANSFAC-Logo

TRANSFAC FACTOR TABLE, Release 2017.2 - public - 2017-06-30, (C) QIAGEN


AC T00792 XX ID T00792 XX DT 15.10.1992 (created); ewi. CO Copyright (C), QIAGEN. XX FA tat XX SY tat; transactivating regulatory protein. XX OS HIV-1, human immunodeficiency virus type 1 OC viridae; ss-RNA enveloped viruses; positive strand RNA viruses; retroviridae; lentivirinae XX SF zinc ion-dependent [1]; SF inactivation of tat through reducing (but not through metal chelating) reagents [3]; SF DNA topoisomerase I inhibitor camptothecin inhibits tat-mediated transactivation of HIV-1 LTR [2]; XX IN T02727 cyclinT1; human, Homo sapiens. IN T00782 TAFII55; human, Homo sapiens. XX BS R02421. XX DR TRANSPATH: MO000025176. XX RN [1]; RE0002447. RX PUBMED: 2247474. RA Cordingley M. G., LaFemina R. L., Callahan P. L., Condra J. H., Sardana V. V., Graham D. J., Nguyen T. M., LeGrow K., Gotlib L., Schlabach A. J., Colonno R. J. RT Sequence-specific interaction of Tat protein and Tat peptides with the transactivation-responsive sequence element of human immunodeficiency virus type 1 in vitro RL Proc. Natl. Acad. Sci. USA 87:8985-8989 (1990). RN [2]; RE0008818. RX PUBMED: 8125909. RA Li C. J., Wang C., Pardee A. B. RT Camptothecin inhibits Tat-mediated transactivation of type 1 human immunodeficiency virus RL J. Biol. Chem. 269:7051-7054 (1994). RN [3]; RE0009763. RX PUBMED: 8132560. RA Koken S. E. C., Greijer A. E., Verhoef K., van Wamel J., Bukrinskaya A. G., Berkhout B. RT Intracellular analysis of in vitro modified HIV Tat protein. RL J. Biol. Chem. 269:8366-8375 (1994). XX //